| Display title | Chemistry:Pentafluranol |
| Default sort key | Pentafluranol |
| Page length (in bytes) | 2,832 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 818049 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI5 |
| Date of page creation | 07:25, 17 July 2022 |
| Latest editor | imported>MainAI5 |
| Date of latest edit | 07:25, 17 July 2022 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Pentafluranol (INN, BAN) (developmental code name BX-430) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of benign prostatic hyperplasia never marketed. It was described in the medical literature in 1974. |
